SCHEMBL3201676

SCHEMBL3201676

CC1C(=O)N(Cc2ccccc2)CC1N

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.50
HPGD P15428 1/20 0.45
TSHR P16473 1/20 0.45
GRM2 Q14416 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
BRD4 O60885 1/20 0.43
PREP P48147 1/20 0.43
CACNA1G O43497 1/20 0.42
CACNA1H O95180 1/20 0.42
CACNA1I Q9P0X4 1/20 0.42
ACE P12821 1/20 0.42
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
EHMT2 Q96KQ7 1/20 0.41
DDB1 Q16531 1/20 0.41
CRBN Q96SW2 1/20 0.41
SIRT1 Q96EB6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3185962 1.00 DPP4 (0.50) DPP4HPGDTSHRGRM2L3MBTL1
SCHEMBL3201687 1.00 DPP4 (0.50) DPP4HPGDTSHRGRM2L3MBTL1
SCHEMBL13484174 0.83 HPGD (0.47) HPGDTSHRGRM2L3MBTL1BRD4
SCHEMBL9766998 0.82 HPGD (0.46) DPP4HPGDTSHRGRM2L3MBTL1
SCHEMBL27623771 0.81 BRD4 (0.47) DPP4HPGDTSHRGRM2BRD4
SCHEMBL10375649 0.79 CCKBR (0.45) BRD4PREPCACNA1GCACNA1HCACNA1I
SCHEMBL9803156 0.78 HPGD (0.43) HPGDTSHRGRM2L3MBTL1BRD4
SCHEMBL9802568 0.78 HPGD (0.43) HPGDTSHRGRM2L3MBTL1BRD4
SCHEMBL9803167 0.78 HPGD (0.43) HPGDTSHRGRM2L3MBTL1BRD4
SCHEMBL9767456 0.78 HPGD (0.43) HPGDTSHRGRM2L3MBTL1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE41149-E1 Stereoisomerically pure 7-[(7S)-7-amino-5-azaspiro[2.4]heptan-5-yl]-6-fluoro-1-[(1R,2S)-2-fluoro-1-cyclopropyl]-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid or a pharmaceutically acceptable salt thereof; antibacterial agents DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-02-23 US disclosed
US-RE41149-E1 Stereoisomerically pure 7-[(7S)-7-amino-5-azaspiro[2.4]heptan-5-yl]-6-fluoro-1-[(1R,2S)-2-fluoro-1-cyclopropyl]-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid or a pharmaceutically acceptable salt thereof; antibacterial agents DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-02-23 US disclosed
US-RE41149-E1 Stereoisomerically pure 7-[(7S)-7-amino-5-azaspiro[2.4]heptan-5-yl]-6-fluoro-1-[(1R,2S)-2-fluoro-1-cyclopropyl]-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid or a pharmaceutically acceptable salt thereof; antibacterial agents DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-02-23 US disclosed
US-6031102-A Optically active pyridonecarboxylic acid derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2000-02-29 US disclosed
EP-0341493-B1 Optically active pyridonecarboxylic acid derivatives DAIICHI SEIYAKU CO (JP) 1999-07-14 EP disclosed
US-5767127-A BACTERICIDES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1998-06-16 US disclosed
CN-1033751-C Optically active pyridonecarboxylic acid derivatives DAIICHI SEIYAKU CO (JP) 1997-01-08 CN disclosed
US-5587386-A BACTERICIDES, MICROBIOCIDES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1996-12-24 US disclosed
US-4996224-A 1-benzyl-4- or 5-pyrrolidinomethyl-pyrrolidin-2-ones and nootropic method of use thereof BOEHRINGER INGELHEIM KG (DE) 1991-02-26 US disclosed
CN-1037507-A Optically active pyridone carboxylic acid derivatives DAIICHI SEIYAKU CO (JP) 1989-11-29 CN disclosed
EP-0341493-A2 Optically active pyridonecarboxylic acid derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1989-11-15 EP disclosed
US-4767759-A ANTIHYPOXICS BOEHRINGER INGELHEIM KG (DE) 1988-08-30 US disclosed